Targeting Transcriptional Enhanced Associate Domains (TEADs)

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Transcriptional Enhanced Associate Domain (TEAD) proteins are crucial downstream effectors of the Hippo signaling pathway.
• TEADs regulate fundamental cellular processes including proliferation and stem cell maintenance.
• Dysregulation of TEADs is observed in numerous cancers, correlating with adverse patient outcomes.

Purpose of the Study:

• To review recent structural data of TEAD proteins in complex with coactivators and inhibitors.
• To explore the therapeutic potential of targeting TEADs in cancer and regenerative medicine.

Main Methods:

• Literature review of recent structural studies on TEAD proteins.
• Analysis of TEAD protein-coactivator and TEAD protein-inhibitor complex structures.
• Discussion of pharmacological targeting strategies for TEADs.

Main Results:

• Recent structural studies provide detailed insights into TEAD interactions with coactivators (YAP, TAZ, VgLL, p160) and inhibitors.
• TEAD protein expression is elevated in gastric, colorectal, breast, and prostate cancers.
• Structural information can guide the development of novel TEAD-targeting therapeutics.

Conclusions:

• TEAD proteins represent promising therapeutic targets due to their role in cancer and stem cell biology.
• Understanding TEAD structures is vital for designing effective pharmacological modulators.
• Targeting TEADs holds potential for advancing cancer treatment and regenerative medicine strategies.